What You Should Know:
2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions.
– The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to make informed decisions about powerful pain medications, anticoagulants, antiemetics or other drugs they may prescribe for patients.
– By working with 2bPrecise, USOA will be bringing the benefits of PGx directly into its members’ provider workflows so they can make more informed decisions about powerful pain medications, anticoagulants or other drugs they may prescribe to patients.
